FGF23 and chronic kidney disease: We postulate that these direct FGF23 actions on the myocardium, at least initially, may have beneficial effects that with increasing serum FGF23 concentrations and exposure time transition into pathological cardiac remodeling leading to a decrease in cardiac function, as observed in animal models with CKD.